Pharma Journalist -

ContraVir Pharmaceuticals, a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis…
Read More...

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance its functional…
Read More...

SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced to launch Bivalirudin…
Read More...

Sartorius Stedim Biotech (SSB) launched a new vessel for its ambr 250 modular benchtop automated mini bioreactor system. The single-use vessel has been specially designed for…
Read More...

SMi Reports: Alexion Pharmaceuticals and Minoryx Therapeutics to deliver presentations at the 9th Annual Orphan Drugs and Rare Diseases Conference The orphan drugs market recently…
Read More...

Liquidia Technologies announced that it has amended its collaboration agreement with GlaxoSmithKline (GSK) for the development and commercialization of pharmaceuticals based upon the…
Read More...

Mölnlycke and Zuellig Pharma have announced a new partnership that will focus on providing more advanced wound care products and solutions to patients and healthcare practitioners…
Read More...

SMi Group reports: After the launch of Rocklatan in the USA, Aerie Pharmaceuticals will be discussing plans for a European approval at the Ophthalmic Drugs conference this November…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for use with other medicines to treat chronic…
Read More...

SMi Reports: Interview with expert speaker from Alliance for Safe Biologic Medicines (ASBM) released for the 2019 Biosimilars conference The 10th annual Biosimilars conference will be…
Read More...